Jyothy Labs Limited (532926) Earnings Call Transcript & Summary

November 4, 2026

BSE Limited IN Consumer Staples Household Products earnings 45 min

Earnings Call Speaker Segments

Operator

operator
#1

Good day, everyone. Thank you for joining us for Jyothy Labs Limited's Q2 and FY '27 earnings conference call. ICICI Securities is hosting today's call on behalf of Jyothy Labs Limited. <<operator_script>> At this point, I'll turn the conference over to Mr. Nitin of ICICI Securities. Thank you, and the floor is yours, sir.

Analyst

analyst
#2

Hello, and many thanks. ICICI Securities is truly delighted to have Jyothy Labs' management team with us for the Q2 FY '27 earnings call. Representing management, we have Ms. Jyothy, Chairperson and Managing Director, along with Mr. Pawan Agarwal, Chief Financial Officer. At this point I'll pass the call to Ms. Jyothy for her opening remarks. Thanks, and the floor is yours, ma'am.

Moothedath Jyothy

executive
#3

Thank you. Good afternoon, everyone, and welcome to the Q2 FY '27 earnings call for Jyothy Labs. The investor presentation and our financial results can be found on the stock exchanges and on our website. I hope you have had a chance to go through them. During the quarter, consumer demand proved relatively resilient. Rural markets keep outpacing urban ones, even though urban consumption is displaying signs of a gradual recovery. Strong growth continued in modern trade, e-commerce and quick commerce, while general trade stayed subdued. The FMCG sector is still operating in a difficult environment, with geopolitical uncertainty, elevated commodity prices and shifting consumer behavior weighing on both growth and profitability. The continuing conflict in West Asia has led to sharp rises in costs for crude derivatives, chemicals and packaging, while the deficient monsoon has created concerns about agricultural output, food inflation and rural purchasing power. For the industry, the immediate challenge is to manage input cost inflation without harming consumer affordability and demand. With that as context, let me turn to how Jyothy Lab performed. Profitability was especially challenging in Q2, even as our underlying business kept delivering healthy growth. Revenue from operations rose 3.3% to INR 760 crore, while reported volumes fell marginally, mainly reflecting the exit of the Pril and Fa businesses after the brand license agreement expired in May 2026.

Moothedath Jyothy

executive
#4

Leaving Pril and Fa aside, the business achieved solid value growth of 12.4% and volume growth of 8.1% in the quarter, with support from our core brands, selective pricing, new launches and expansion of distribution. During the first half, growth came in at 10.2% in value and 6.2% in volume. Those figures give a better picture of how our underlying business is performing. Looking across distribution channels, general trade stayed subdued, whereas modern trade kept up double-digit growth and e-commerce along with quick commerce maintained strong momentum. We remain focused on raising distribution productivity and improving execution across channels. Turning to category performance, Fabric Care is still the growth leader, posting 10.4% value growth. Detergent powders and bars held on to their growth momentum. Liquid detergents rose by more than 50% year-on-year, led by Henko, Ujala, MoreLight and Mr. White. Ujala Young & Fresh, our fabric conditioner, keeps performing well, which reinforces our confidence in these emerging formats and their potential for long-term growth. Excluding Pril, Home Care grew 15.3%, driven mainly by volumes. In dishwash, Exo posted an encouraging 23% growth, backed by new variants, liquids, broader distribution and brand investments. Our campaigns with Yami Gautam and Keerthy Suresh have helped build consumer awareness and interest. In HI, improving profitability stays our priority while we actively pursue growth in the liquid vaporizers format.

Moothedath Jyothy

executive
#5

At this point, Coil accounts for 30% to 35% of the HI portfolio, versus 43% to 45% twelve months earlier. We keep reinforcing our position in liquid vaporizers, aerosols and other formats. In the quarter, we rolled out Maxo Agarbatti featuring a formulation approved by the government. That rounds out a key element of our portfolio expansion, and our attention is now on scaling these newer formats to more -- to underpin more profitable growth. Personal Care posted value growth of a little over 11%, helped by pricing moves on Margo and a favorable base after last year's GST transition. We also introduced Margo Gentle, a glycerin bathing soap offered in argan oil and moringa oil variants in select markets. Even so, steep rises in palm oil, neem oil and other ingredients weighed on profitability. Even with price hikes of roughly 10% to 12%, the cost escalation could not be fully absorbed. Our priority stays the same: strengthening the Margo franchise while progressively restoring category margins. I'll now move to our financial performance. Revenue from operations came in at INR 760 crores, against INR 736 crores a year ago. The biggest challenge this quarter was the unprecedented jump in raw material and packaging costs, which squeezed gross margin to 34.8%, down from 48.1% last year and 38.5% in the prior quarter.

Moothedath Jyothy

executive
#6

Crude derivatives, LABSA, SLES, soap noodles, palm oil, and packaging materials all saw especially sharp inflation. Compared with levels that existed before the West Asia conflict, HDPE and polypropylene prices are up roughly 55% to 60%, and packaging now makes up about 18% to 20% of our cost base. Crude-linked inputs account for almost 60%, 65% of our consumption basket. With inflation in crude and crude derivative inputs abnormally high and persistent, the company's gross margins have been materially affected over the last few months. High-cost finished goods held in inventory continued to weigh on margins during the quarter, even though commodity prices had softened somewhat at the start of the quarter, especially in July and early August. Near-term uncertainty has nonetheless grown because of renewed inflationary pressure in October. We took pricing actions of approximately 4%, which were reflected in the business during the quarter, but those steps could not entirely offset higher input costs. We are assessing additional selective pricing and grammage adjustments, especially in lower unit packs, while staying mindful of consumer affordability. Procurement efficiencies, value engineering, product mix improvements, and cost discipline are supporting these measures without compromising product quality.

Moothedath Jyothy

executive
#7

Employee costs rose roughly 5.7% year-on-year and came in at just under 12% of revenue. Advertisement and promotion spend was 7.4% of revenue, about 100 basis points up sequentially, which mirrors what we're putting into new launches and brand development. Other expenses were roughly 13% of revenue versus 12.1% last year, mainly because of higher freight and logistics costs, including significantly higher export shipping costs and general inflation across various operating cost items. As a result, operating EBITDA margin fell to 2.5% from 16.1% last year. Operating EBITDA came in at INR 19 crore, while profit after tax is INR 10.6 crore. We know this level of profitability is well below what we expect. Our near-term priority is to recover margins through calibrated pricing, cost efficiencies and an improved product mix, while keeping up the growth momentum of our core businesses. Given where commodities stand today, margin recovery is likely to come progressively rather than right away. For first half FY '27, revenue from operations was INR 1,533 crores, which means reported value growth of 3.1% and a marginal decline in volume. Excluding Pril and Fa, value and volume growth were 10.2% and 6.2%, respectively. Gross margin for H1 was 36.7% versus 48% last year, while operating EBITDA margin is 5.5% against 16.3% in the corresponding period.

Moothedath Jyothy

executive
#8

For the first half, our effective tax rate came in at 28.4%, and for the full year we anticipate it staying in the vicinity of 25% to 26%. As of September 2026, net working capital rose to 23 days, up from 15 days in March, largely because of higher inventories. Material cost inflation has pushed inventory levels higher in value terms, while inventory volumes have stayed broadly consistent. We expect working capital to gradually come back to our medium range of 18 to 20 days as conditions stabilize. Importantly, our balance sheet remains strong, with roughly INR 846 crores in cash and 0 debt, which gives us financial flexibility to support our growth priorities. I would now like to briefly address an important capital allocation decision taken by the Board. The Board has approved a share buyback of INR 147 crores through the tender offer route at a price of INR 215 per share. We believe the prevailing market valuation does not adequately reflect the underlying strength of our brands, growth potential and financial position. The buyback reflects our confidence in the company's long-term fundamentals and our commitment to disciplined capital allocation. Importantly, the promoters and the promoter group, including persons in control, will not participate, allowing eligible public shareholders to benefit from the buyback subject to applicable regulations.

Moothedath Jyothy

executive
#9

Profitable organic growth investment stays our top priority. We'll keep assessing acquisitions that complement us, stick with our dividend payout policy of 35% to 50% of profit, and keep the balance sheet strong and debt-free. The buyback should help support financial metrics, including earnings per share and return on equity. Let me wrap up with the Q3 outlook and our near-term priorities. Sustained growth in Fabric Care, especially liquid detergents and fabric conditioners, while building on Exo's strong momentum, improve HI profitability by strengthening the product mix and scaling newer formats, particularly Maxo Agarbatti. Strengthen Margo through innovation, calibrated pricing and distribution expansion with a clear focus on margin recovery, continue investing in our brands, new launches and distribution capabilities across traditional and emerging channels; progressively restore profitability through pricing, procurement efficiencies, value engineering and disciplined cost management. We expect the underlying business to sustain healthy growth during Q3, led by Fabric Care and supported by our new products. However, gross margins are likely to remain under pressure and a full recovery in H2 cannot be assumed unless the commodity prices moderate and remain stable. The past 2 quarters have tested our profitability, and we recognize the seriousness of these challenges.

Moothedath Jyothy

executive
#10

Our teams are tackling those issues quickly and with discipline. Meanwhile, the solid expansion in our underlying business, the ongoing strength of our core brands, and the promising results from new launches give us confidence. Our balance sheet is still strong. Our brands keep earning consumer trust, and the long-term opportunities in Home Care and Personal Care are still intact. Our immediate job is to turn this business strength into improved profitability. Although the near term remains difficult, we stay confident in our direction and dedicated to building a stronger, more competitive and profitable Jyothy Labs. Before I finish, I want to thank our employees for their dedication, our trade and distribution partners for their ongoing support, and our investors for their trust and constructive engagement. Thank you for your time today. We will now be glad to take your questions.

Operator

operator
#11

<<operator_script>> Our first question comes from Rushabh Shah, who is calling in from BugleRock PMS.

Rushabh Shah

analyst
#12

The first thing I want to ask about is that during these calls, you've said the aim is to return to the margins we had before. So I just wanted to understand what actions we're taking to reach those prior margins we used to command, setting aside things like raw material fluctuations. So what are we doing? Are new products being introduced? Or do we have some fresh pipeline of new product launches? And if so, in which category will those products be launched? Or are we raising our spend on advertising?

Moothedath Jyothy

executive
#13

So Rushabh, yes, the NPDs are part of it, since they come with a better margin profile. As you know, margins in detergents are largely not very encouraging. And on top of that, when raw material prices rise, the impact is really severe. That's one thing. And the second is the product mix we sell, right? So while LUPs have been a strong part of our overall portfolio for us, especially for reaching -- for having large-scale distribution, and it helps us reach further in the country when it comes to traditional trade and all of that. So when it's an LUP, you know, there's a certain -- it's a fixed price, and therefore the hit is even higher. So we're trying to see how to manage those -- the overall product mix in our portfolio. So yes, one is -- so these are the 2 actions. The rest is all the cost efficiencies we're trying at the back end.

Rushabh Shah

analyst
#14

Alright, my next question was about the dishwash segment. So, given that Pril was a premium product in that segment, and now we're showcasing Exo and have also launched the Exo premium product to replace Pril, do you think Exo — which is already in people's minds, which we used to showcase as a less premium brand compared to Pril — can it take Pril's place in the premium segment? Or should we be looking out for a premium brand in an inorganic segment completely different from Exo?

Moothedath Jyothy

executive
#15

Right. So Rushabh, Pril was priced at a premium — it carried a premium over every brand in the market. The only issue is that the brand is no longer there. Apart from that, we're on equal footing with the competition. So now, after Pril, it's just the competition and us in that segment. That means there are no premium brands in this category at present. So that's one point. And when you say premium, it wasn't that it was priced very highly above us and the competition. It was slightly better, since that was the first brand to enter the country and it had a premium image. We carried on with that. That said, Exo enjoys far bigger equity than the brand — the other brand. And therefore, we're highly confident of performing much better going forward.

Rushabh Shah

analyst
#16

Alright, so my third question concerns brand building. We’ve operated in this business for many years and have built brands in dishwash, in detergent, and in liquid washes. However, we haven’t managed to achieve the same in Personal Care, specifically with the Margo brand. So I just wanted to understand what kinds of challenges we’re encountering when building a brand there. I’d like to hear your thinking on this, because we have highly successful brands in the other 2 segments. Yet with Margo, we haven’t been able to crack it...

Moothedath Jyothy

executive
#17

Yes, Rushabh, I understand. It's not that Margo is beyond our ability to figure out. When we obtained the brand — when we bought Margo — it stood at a very different point than it does today. Over the many years we've owned it, Margo has performed extremely well. For Margo, moving into other segments is the next step. This brand is strong in numerous regions across the country, and people hold it in very high regard. It is a brand that has endured for more than 100 years. That, then, is the brand's strength, which speaks for itself — for all of it. We're working to draw more from the brand, and you will see those examples arrive in the future.

Rushabh Shah

analyst
#18

So, ma'am, my question is really this: the brand has existed for 100 years, but the margins we ought to command for a 100-year brand — are we looking to command margins like that, similar to what we're doing in the other segments?

Moothedath Jyothy

executive
#19

Look, the brand has enjoyed better margins in the past. What's happening right now is something every brand is going through — the problem of prices, of raw material costs that have risen. Apart from that, the brand is well positioned for its next phase of growth.

Operator

operator
#20

Our next question comes from Amit Purohit at Elara.

Amit Purohit

analyst
#21

Turning to the margin side, I'd like to get a sense of the type of cost inflation you've been seeing. It appears quite sharp—even steeper than during FY '22 and '23, when there was a margin decline, but this has been far more severe. Meanwhile, our price increase is only around 4%. So I'd like to know how much of a price increase we need now. And also, why aren't we able to implement a significant price increase, given that we see other players raising prices, particularly in the Fabric Care Segment and also in the Home Care Segment. That's my first question.

Pawan Agarwal

executive
#22

Thanks, Amit, for that question. So looking at the margin erosion we're seeing year-on-year, RMPM accounted for close to 18% in quarter 2. And that was partly offset by roughly 4% from a sales price increase, plus a little bit of mix. So the net effect is 13%, a 13.5% impact on gross margin for the quarter. On the price — the RMPM price increases, what we saw was across all key raw material and packaging material, including LABSA, SLES and soap noodles, neem oil, chemicals — we saw an inflationary trend in every one of the critical raw materials. And as we said in our opening remarks, 60% to 65% of our cost base is linked to crude derivatives. So it has hit us harder. Now, on your second point about the pace of price increases. First of all, we'd like to clarify that we don't see a structural deterioration in the economics of our business. It's a temporary issue, caused by inflationary trends in our key raw materials and packaging materials. We took — as I said, we took about 4% price increases across our portfolio, and the price increases — the degree of price increases varies across segment, brand, SKUs, geography, et cetera.

Pawan Agarwal

executive
#23

The rationale behind choosing a smaller price hike over 1 quarter or 2 quarters was our reluctance to harm consumer affordability or market share by raising prices indiscriminately in a rushed manner. We do recognize that growth must be profitable. Yet once more, the aim is for us to apply calibrated pricing. And in the -- this approach brings short-term pain, but over a long period of time the long-term franchise and brand credibility stay intact. Your third point concerned how much additional pricing increase is needed, et cetera, to restore historical margins. So look, further pricing actions are being taken across product categories and SKU within our portfolio as we speak. Still, pricing by itself cannot close the whole inflation gap of 13%, 14%. Margin recovery must arrive through multiple levers, not pricing by itself. Pricing, procurement, value engineering, mix and operating leverages, et cetera, are all significant levers of margin recovery for us. We will basically balance 3 things: input cost recovery, competitive pricing and affordability. And this recovery is going to be progressive as we have been maintaining, until the time the commodity prices stabilize, the margin recovery is going to take time, and it will be progressive.

Pawan Agarwal

executive
#24

It'll creep up gradually and steadily. And beyond raising prices, there's plenty we're doing.

Amit Purohit

analyst
#25

Sure. Just 2 quick follow-ups, then. First, I'd like to understand if the mix has gotten worse in any respect, such that the fabric wash segment's margin profile has come under pressure compared with — because my assumption is that liquids would be performing well. So in effect, does this make our margin profile for the category better, or is it roughly neutral?

Pawan Agarwal

executive
#26

No. As we've said before, liquid detergents right now have economics that are somewhat different, since that category is still scaling and calls for investment in converting consumers. But the strategic opportunity in front of us is a significant one. Better penetration, benefits from scale, procurement efficiency, a richer mix, and so on should steadily enhance unit economics in liquid detergent. And considering how quickly consumer adoption is developing, not taking part aggressively would carry substantially greater strategic risk. So yes, compared with powder, liquid detergents currently command a lower margin. But beyond that -- and it's a category that is growing, expanding at upwards of 50% each quarter. So that does have some bearing. But for the most part, the impact you're seeing in Fabric Care segment margin comes largely from the input cost.

Amit Purohit

analyst
#27

All right, and then one final thing: what's the right way to frame the mix for FY '27, or perhaps some sort of road map? I get that this is a volatile stretch, but I just want a feel for how we should view margin in the second half. You said gradual, but would it be like exiting at double digit, or which one should be high? And how should we think about that?

Pawan Agarwal

executive
#28

Look, internally we aim to keep delivering double-digit growth even amid the current volatile conditions, and we're set up for that. Given the external environment, the geopolitical situation and the input inflation we're seeing and witnessing, which is unprecedented, FY '27 ought to be viewed as an aberration year. So at this stage, looking at the situation, providing any kind of guidance is hard for us, but rest assured we're working toward sustaining the growth momentum, and the performance of our categories and of brands Ex, Pril and Fa gives us confidence that we should be able to do that. Margin is a tricky one. It's largely shaped by external factors. So depending on stability in commodity prices, margin recovery should start. That's what we're looking at in H2 right now.

Operator

operator
#29

Vishal Gutka from ASK Investment has the next question.

Vishal Gutka

analyst
#30

Vishal here. Madam, I recall the medium-term aspiration for revenue growth — a target of INR 5,000 crore, correct? That was a target set for roughly 3 years, 4 years out. And one media interview mentioned that M&A is on hold for the time being, and Pril is also no longer in the base now. So how do you plan to reach that figure? Because for that figure, I think you're at a run rate of about INR 3,000 crore now. To hit that figure over the next 3 to 4 years, I think it needs a run rate of about 15% to 20% for that number to be achieved. Just wanted your thoughts. I think a couple of times you've mentioned that personal care is a space where you'd like to do much more. If you can broadly highlight, in the context that Pril is not there and M&A has been put on hold as of now, how would you plan to achieve that number?

Moothedath Jyothy

executive
#31

First off, Vishal, INR 5,000 crore remains our target — that's definitely still what we're aiming for, correct? Where the notion that M&A has been put on hold came from, I honestly don't know. It isn't on hold for this. What I'd say is that we're waiting for the right opportunity. So "holding" is quite the wrong word — perhaps over there, I'm not sure what gave you that impression. The point is that we aren't rushing into an M&A simply for its own sake, right? This isn't a 1 day news item that we have to manage — along with the news, we have to manage the company or the brand we'll be acquiring, and in a manner that benefits the overall company in a good way, that the brand grows, and then that there's a good runway for that brand to grow. So we aren't looking at anything of the short-term news-making variety. We're looking at everything with a long-term objective. Given that scenario, we are constantly evaluating a great many opportunities that are coming. But there has to be — we have a certain checklist for why one should go for an acquisition or why we should back out.

Moothedath Jyothy

executive
#32

We're sticking firmly to that approach. That's why, whenever an opportunity arrives in the proper manner — the way we'd like it to — we will certainly be evaluating it. That said, we're also attempting to drive growth through the fact that we have plenty of NPDs in the pipeline too. So those will likewise form part of the INR 5,000 crore growth journey, as we try to build or create brands with a stronger margin profile going forward, so that your overall margins on average rise somewhat. That's the intention. So nothing is on hold as such. It's just that we're waiting for the right opportunity.

Vishal Gutka

analyst
#33

Understood. And ma'am, looking back, detergent and MoreLight have been huge successes, and Ujala Young & Fresh has also performed well to some degree. So what else can be done, since this incremental revenue is INR 2,000 crore that needs to be delivered over the next 3 to 4 years? And in the categories where you already operate — maybe liquid detergent, maybe dishwash, and all of that is happening — most of them appear quite well consolidated. I just wanted your thoughts on how we get to that number. NPDs are certainly one avenue available to you, but within NPD, if you could broadly elaborate, what are you trying to do?

Moothedath Jyothy

executive
#34

Look, at this moment, I don't want to — we've already pinpointed a handful of categories. And you'll be seeing those sorts of developments over the coming year. So for now, I'd hold myself back from offering any category guidance. That said, yes, it will show up in a better profile and all of that. The nicest part is that essentially every one of our new launches from the past 2 or 3 years has enjoyed reasonable success and, in fact, is performing well. So we're carrying that momentum forward. And we're likewise hopeful that our upcoming line of NPDs will deliver too. The team stands ready. The distribution channel is available to us. The brand building work we kept doing on an ongoing basis — those elements remain with us. We've got the team alongside us. So the right ingredients are present for a successful mix, and the launches are all in place with us. It's — whatever we're dealing with at present is a temporary phase. But when it comes to growth, the fundamentals, every one of them is in place. So there's nothing to worry about on that front. We have a solid lineup of things that are going to happen.

Operator

operator
#35

<<operator_script>> Our following question comes from Navin with ithoughtpms.

Navin Koushik M

analyst
#36

Yes. First, congratulations on delivering resilient results amid such difficult conditions. So my first question concerns Margo. I'd like to bounce one thing off you about the overall market perception I've observed. Please correct me if I'm mistaken. But over roughly the last decade, a shift has occurred away from natural herbal-style products and toward personal care items built on science-backed, transparent formulations. So I just want to hear your views on that whole dynamic, and given that Margo operates in the less favored segment within this dynamic, how do you see its market position, and how favorably or unfavorably is it placed right now?

Moothedath Jyothy

executive
#37

Okay Navin, that's a fair point, but the natural segment hasn't suddenly become empty, correct? And it's not as though every consumer has shifted over to the other portion of the segment or to this new-age thing you're referring to. Margo remains very firmly established, or very widely recognized, for its natural attributes — particularly the name itself. That said, we are — and that's performing quite strongly. There are still loyal consumers, and they continue among the younger age group. We achieved tremendous success, which we witnessed when we ran the Durga Puja activity in the home state, right? All the young consumers, including Gen Z and all of that, they all have faith in the brand, right? So that demonstrates there's still very much a place for natural. And having said that, we've also introduced the new-age Margo into — in the glycerin segments with Moringa, and those are the new-age ingredients in the natural space that we've launched. First, you — Margo is very widely recognized for its natural space. You can't abandon that space, right? So we need to hold on to what we're strong at.

Moothedath Jyothy

executive
#38

We need to build on what we're good at. So Margo is going to keep expanding along that path. As for the other opening, we'll go after it with different brands or perhaps a new brand, rather than putting it under Margo. Margo still has, and natural space still has, plenty of consumers and plenty of acceptance. Everything goes through a certain stage — it arrives, it departs. That's just how I see it: everything has its place, and it isn't at 0 yet. So yes.

Operator

operator
#39

Moving on, our next question comes from Harshad Sheth at ICICI Securities.

Analyst

analyst
#40

Okay, a few questions. First, with Pril and Fa leaving, distributors would have dropped 2 significant SKUs from their basket. So what impact has that had on distributor ROI? And have you adjusted the terms of trade—whether that's better margins, schemes, or longer credit—to keep them involved while Exo Liquid scales up? I'm asking because working capital days have shifted from 15 in March to 23 in September. So how much of that comes from receivables versus high-margin inventory?

Pawan Agarwal

executive
#41

Look, Harshad, the exits of Pril and Fa have made no difference to our distribution terms, particularly in general trade and modern trade. On ROI and similar items, we have raised nothing—everything remains at the previous level. Credit has not been expanded by us. As a matter of fact, our debtor days have fallen. Comparing March with September, debtor days have dropped considerably. The working capital increase, which we noted in our opening remarks, sits mostly in inventory—raw material and finished goods, chiefly finished goods—driven by the higher material cost. That explains the rise, a modest rise, in working capital. So fundamentally, nothing has shifted. And Exo liquid is progressing very well. There are no problems with it. Therefore, the departure of Pril and Fa has had zero impact on trade terms.

Analyst

analyst
#42

Thank you. And sir, second, picking up on what was said regarding Margo. You noted that naturals are the priority for Margo. That category is crowded, with Santoor, Medimix, Patanjali and Himalaya in the mass segment and a number of new D2C brands at the premium end. So what makes Margo capable of winning there? Is it the neem heritage, the price point, or regional strength? And second, is this something you're prepared to put margins behind, with dedicated A&P and new formats such as Margo Gentle, or will it scale up gradually within the existing margin structure? Broadly, over the coming 3 years, what would success look like in terms of, say, market share or segment size? I ask because personal care, including Fa as well, has seen somewhat flat growth across the last 3 years.

Moothedath Jyothy

executive
#43

Look, Harsh, that's exactly why Margo has kept growing. If you look at last year, we did really well with the brand. Our consumers trust it 100%. The next step is taking that brand into its next growth phase through extensions and similar moves, and as a team we're already working on that. So Margo still holds plenty of potential. It's a brand people trust deeply. And yes, that's it. We have many plans for the brand. That said, it's one of those Personal Care brands that will grow in a particular way. We also have other plans for the Personal Care segment. Not all of it will sit under Margo. So I think that answers your question.

Analyst

analyst
#44

Okay. Then finally, you have roughly INR 850 crores in cash, you're running a buyback, and you also mentioned selective inorganic growth. So how should we think about allocating capital between returning cash and making acquisitions? You did say the M&A plan isn't on hold. And if you do pursue inorganic options, would that be new adjacencies, such as in D2C BPC spaces, or would it deepen existing categories? And what deal size or return thresholds would you consider?

Pawan Agarwal

executive
#45

So Harshad, the Board evaluates this capital allocation question on an ongoing basis. And the buyback decision announced today came out of deliberations at the Board level. As for M&A, we keep pursuing acquisition opportunities and are searching for the right fit. We're mindful of how much cash the business can generate. And so how we use that cash will be determined on a case-by-case basis. The company's dividend payout ratio and dividend policy stay in effect, and dividends will keep being paid to shareholders. So by and large, dividends, acquisitions, and investment in new products and NPDs and new categories — that's where the cash will go.

Operator

operator
#46

Our following question comes from Navin with ithoughtpms.

Navin Koushik M

analyst
#47

I just wanted to ask how you view crude — or rather, the dependence on crude. So you just pointed out that roughly 65% of our overall cost is tied to crude, correct? So do we see this as a big threat? And are we doing something to kind of lower that reliance on one raw material, or is that not something we concern ourselves with, and we're more focused on, say, a new brand or new products? If you could just shed some light on that, that would be great.

Pawan Agarwal

executive
#48

Look, unfortunately the crude dependency exists in the near term, but as we said on an earlier call, our NPD pipeline is strong, and we're working on various products with far less crude dependency and better margin profiles. So we recognize that this unprecedented rise in crude prices has hit the profitability of the business. And this product development effort has been underway for a fair amount of time. So hopefully next year we would see — we should see some solid products that have lower dependency on crude.

Navin Koushik M

analyst
#49

Understood — that's really useful. One last thing I'd like to ask. I'm curious about your thinking on launching a brand from scratch from here. So I get that they're seeking brands through M&A, and we're doing NPDs. But I'd just like to hear whether you're even considering the notion of building a brand internally at this point.

Moothedath Jyothy

executive
#50

Yes. Yeah, Navin, we've given that some consideration. Those would be new categories.

Operator

operator
#51

Pankaj, an individual investor, has the next question on the line.

Speaker

unknown
#52

You just responded regarding the reliance on crude, so I'm good.

Operator

operator
#53

Since no more questions have come in from the participants, that brings this conference to a close on behalf of Jyothy Labs Limited. We appreciate your participation. You can go ahead and disconnect your lines now.

Pawan Agarwal

executive
#54

I appreciate that.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Jyothy Labs Limited transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to Jyothy Labs Limited earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Jyothy Labs Limited or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.